IFNG and non-small cell lung carcinoma: Numerous clinical trials treating patients with NSCLC with DC vaccine monotherapy have reported significant increases in IFNγ secretion from circulating patient-derived lymphocytes; however, increased secretion is seldom correlated with improved NSCLC survival [200,201,202,203,204].